Why Most Analysts Think FedEx Is a Buy After Earnings
FedEx reported better than expected fiscal second-quarter results after the markets closed on Thursday. Although investors were not happy with results, analysts were fairly positive.
All Work
Chris Lange
Is Robinhood Getting Off Easy From SEC Charges?
Robinhood has been a source of controversy on Wall Street for years now, and this is all coming to a head with the most recent charges from the SEC.
What’s Next for Jabil After Record Earnings?
Jabil reported better than expected quarterly results before the markets opened on Thursday. What comes next?
The Highest-Paying Dividend Stocks to Buy in the S&P 500
24/7 Wall St. looks at some of the biggest dividend yields in the S&P 500 and why they may be worth buying into.
Why Gilead Retreated on Rheumatoid Arthritis Treatment
Galapagos was crushed on Wednesday after the firm, in conjunction with Gilead, announced a new commercialization and development agreement for their Rheumatoid Arthritis (RA) treatment.
DraftKings Bets Big on Gift Cards This Holiday Season
DraftKings announced Tuesday that it would be partnering with a global payments technology company to launch a first-of-its-kind retail gift card.
This S&P 500 Stock Is Up Over 300% This Year
Most investors would think that the best stock in the index would have ties to COVID-19 in some fashion, but online marketplace Etsy has only obliquely benefited from the pandemic.
Why One Analyst Sees Big Upside in This COVID-19 Vaccine Stock
BioNTech was in the spotlight on Tuesday after it received a sizable price target hike from one key analyst.
What Eli Lilly Gets From Its Most Recent Acquisition
Prevail Therapeutics shares absolutely exploded on Tuesday morning after it was announced that the company would be acquired by Eli Lilly.
What This Alexion Acquisition Means for AstraZeneca
Alexion Pharmaceutical shares shot up on Monday after it was announced over the weekend that the company would be acquired by AstraZeneca.
908 Devices Announces Potential IPO Pricing
908 Devices intends to price more than 6 million shares to result in an initial public offering valued up to about $122 million.
How CureVac Is Advancing in the Fight Against COVID-19
CureVac advanced in the fight against COVID-19 by beginning enrollment in its midstage vaccine candidate study. As a result, investors cheered on this news and sent shares higher.
Nio Cashes in Big With Another Huge Secondary Offering
Nio shares dipped on Friday after the electric vehicle manufacturer would be conducting a secondary offering.
Is Lululemon’s Valuation Holding It Back After Earnings Beat?
Although the quarterly numbers were solid, Lululemon stock ultimately fell. This goes to show that even a solid earnings beat can still be trumped by runaway valuations that are hard to justify.
Amazing Comparable Sales Aren’t Enough to Move the Needle for Costco
Costco reported better than expected quarterly results after the closing bell on Thursday.
Does Oracle Deserve More Credit for Q2 Results?
Oracle reported its most recent quarterly results after the closing bell on Thursday.
Broadcom Fails to Impress Despite Solid Earnings Beat
Broadcom reported its most recent quarterly results after the markets closed on Thursday.
Airbnb’s Incredible IPO
Airbnb entered the market with a bang in its IPO on Thursday. The stock came in at $146 above its pricing at $68 per share. This was also well above the expected price range…
Is Major Semiconductor Short Interest Signalling Further Market Highs?
The November 30 short interest data have been compared with the previous report, and short interest in most of these selected semiconductor stocks increased.
Which Big Biotechs Short Sellers Favor Now
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.